Literature DB >> 2478070

Surgery for recurrent colorectal carcinoma--is it worthwhile?

S G Pollard1, R Macfarlane, W G Everett.   

Abstract

A series of 45 patients undergoing a second operation for recurrent colorectal cancer is reported. The majority developed recurrence within 2 years of their initial surgery. Despite regular follow-up, in only 27% of patients submitted to further surgery was the recurrence detected at routine review, and only three of these were asymptomatic at the time of diagnosis. A potentially curative second procedure was undertaken in 47% of cases, with a 2-year survival of 71% and a 5-year survival of 29%. Of those undergoing palliative surgery, this was worthwhile in 64%, providing palliation for more than 6 months. Mean survival following a palliative procedure was 10 months. Palliation was better, and operative mortality lower, when the bulk of the tumour could be removed. In obstructed patients the outcome following palliative resection was better than for palliative bypass procedures. Following resection of metastases there is the prospect of long-term survival, but it is difficult to predict those patients who will do well.

Entities:  

Mesh:

Year:  1989        PMID: 2478070      PMCID: PMC2499017     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  38 in total

1.  Pelvic Recurrence after Excision of Rectum for Carcinoma.

Authors:  B C Morson; E G Vaughan; H J Bussey
Journal:  Br Med J       Date:  1963-07-06

2.  The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy.

Authors:  S Bengmark; L Hafström
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

3.  Reoperation for colorectal cancer.

Authors:  J Mäkelä; M I Kairaluoma
Journal:  Acta Chir Scand       Date:  1986-02

4.  Monoclonal antibody which agglutinates erythrocytes from cancer patients.

Authors:  J Milner; S Metcalfe
Journal:  Lancet       Date:  1982-11-13       Impact factor: 79.321

5.  Sites of recurrent tumour after 'curative' colorectal surgery: implications for adjuvant therapy.

Authors:  J M Gilbert; I Jeffrey; M Evans; A E Kark
Journal:  Br J Surg       Date:  1984-03       Impact factor: 6.939

6.  Local recurrence following 'curative' surgery for large bowel cancer: II. The rectum and rectosigmoid.

Authors:  R K Phillips; R Hittinger; L Blesovsky; J S Fry; L P Fielding
Journal:  Br J Surg       Date:  1984-01       Impact factor: 6.939

7.  Serum CEA in the follow-up of colorectal carcinoma: experience in a district general hospital.

Authors:  T G Allen-Mersh
Journal:  Ann R Coll Surg Engl       Date:  1984-01       Impact factor: 1.891

8.  Surgical treatment of hepatic metastases from colorectal cancer.

Authors:  L Gennari; R Doci; P Bignami; F Bozzetti
Journal:  Ann Surg       Date:  1986-01       Impact factor: 12.969

9.  Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis.

Authors:  P J Finan; R J Marshall; E H Cooper; G R Giles
Journal:  Br J Surg       Date:  1985-05       Impact factor: 6.939

10.  Local recurrence following 'curative' surgery for large bowel cancer: I. The overall picture.

Authors:  R K Phillips; R Hittinger; L Blesovsky; J S Fry; L P Fielding
Journal:  Br J Surg       Date:  1984-01       Impact factor: 6.939

View more
  4 in total

Review 1.  General surgery.

Authors:  I Taylor
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

Review 2.  Follow-up plans after treatment of primary colon and rectum cancer.

Authors:  G Steele
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

3.  Evaluation of a follow-up programme after curative resection for colorectal cancer.

Authors:  J D Howell; H Wotherspoon; E Leen; T C Cooke; C S McArdle
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

4.  Screening and the costs of treating colorectal cancer.

Authors:  D K Whynes; A R Walker; J O Chamberlain; J D Hardcastle
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.